← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2007Last known activity
Nov 30, 2021
Timeline
1990s
- Jan 1, 1995
Institut Català d'Oncologia— Founded
Drugs by trial phase (20 distinct, 14 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (14 own, 0 via acquisition)
Indications
Studied for
- Adenoviridae Infections
- Breast Neoplasms
- Carcinoma
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Endometrial Neoplasms
- Head and Neck Neoplasms
- Heart Diseases
- Melanoma
- Neoplasms
- Pancreatic Neoplasms
- Rectal Neoplasms
- Recurrence
- Squamous Cell Carcinoma of Head and Neck
- Triple Negative Breast Neoplasms
- Uveal Neoplasms
Recent trials (20)
- NCT04953130CollaboratorPhase 4Nov 30, 2021
- NCT04184518Study chairPhase 2Feb 29, 2020
- NCT04197089Study directorPhase 4Dec 31, 2019
- NCT03799744Lead sponsorPhase 1Mar 20, 2019
- NCT03691311Lead sponsorEarly Phase 1Jul 5, 2018
- NCT03366480CollaboratorPhase 1/Phase 2Dec 1, 2016
- NCT02723877CollaboratorPhase 1/Phase 2Apr 1, 2016
- NCT02715596Overall official - principal investigatorPhase 3Dec 1, 2015
- NCT02715596Lead sponsorPhase 3Dec 1, 2015
- NCT02201823CollaboratorPhase 1Feb 1, 2014
- NCT01864759Overall official - principal investigatorPhase 1Jan 1, 2013
- NCT01864759Study chairPhase 1Jan 1, 2013
- NCT01864759Lead sponsorPhase 1Jan 1, 2013
- NCT01531712Lead sponsorPhase 2Jul 1, 2011
- NCT00931450OfficialPhase 1/Phase 2Mar 1, 2009
Details
- Founded
- l'Hospitalet de Llobregat, ES Jan 1, 1995
- Last known activity
- Nov 30, 2021